Allied Market Research
Loading...
Cart
0

Global Varicella Live Vaccine Market Expected to Reach $4,222 Million by 2026

 

Report Code : A03624

quote The demand of varicella live vaccines is on a rise, owing to rise in immunization programs and surge in awareness related to use of varicella live vaccine worldwide. Furthermore, rise in adoption of varicella live vaccines among healthcare providers fuel the market growth. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled,"Varicella Live Vaccine Market by Product, Application, and Provider: Global Opportunity Analysis and Industry Forecast, 2018-2026," the global varicella live vaccine market was valued at $2.71 billion in 2018, and is expected to reach $4.22 billion by 2026, registering a CAGR of 5.7% from 2019 to 2026.

Viral infections can be prevented by immunization and therefore, immunization is crucial. Varicella zoster is a virus that causes diseases such as chicken pox and herpes zoster. However, these infectious diseases can be prevented by the use of varicella live vaccines. Varicella live vaccines are administered to both children and adults in a pattern of two doses to ensure complete immunization. These vaccines contain a weakened form of varicella zoster virus that is effective in creating immunity against the same virus. There are two different types of varicella live vaccines such as monovalent and combination varicella vaccines.

Rise in immunization programs worldwide is the major factor that boost the growth of the varicella live vaccine market. In addition, factors such as surge in awareness related to the use of varicella live vaccines and increase in adoption of varicella vaccination across the globe fuel the growth of the varicella live vaccine market. However, high monetary inputs associated with manufacture of the products restrict the growth of the market. Conversely, growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.

The global varicella live vaccine market is segmented based on product, application, and provider. On the basis of product, the market is bifurcated into monovalent varicella vaccine and combination varicella vaccine. By application, it is divided into chicken pox immunization, herpes zoster immunization and measles, mumps, rubella and varicella (MMRV) immunization.

On the basis of provider, it is segmented into public provider and private provider. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, France, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and, rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Based on product, the monovalent varicella vaccine segment acquired the major share of the varicella live vaccine market and is expected to experience rapid growth during the forecast period as these vaccines exhibit lesser chances of inducing febrile seizures in children as compared to combination vaccines. Moreover, easy availability and presence of large number of products is another reason that boosts the growth of the monovalent varicella vaccine market.

Based on application, chicken pox immunization acquired the largest share of the varicella live vaccine market owing to vaccination employed with an initial aim of building immunity against chicken pox. Herpes zoster segment is expected to grow at the fastest rate during the forecast period owing to surge in geriatric population worldwide and rise in awareness about the use of varicella live vaccines for herpes zoster.

On the basis of region, North America acquired a major share owing to easy availability of varicella live vaccines, presence of skilled healthcare experts, and presence of major key players that offer varicella live vaccines. Asia-Pacific is expected to grow at the fastest rate during the forecast period due to surge in awareness related to importance of immunization and rise in disposable income.

The developing economies offer lucrative opportunities for varicella live vaccine providers to expand their business. The constantly evolving life science industry drives the growth of the market in the developing economies such as India, China, and others.

Key Findings of The Varicella Live Vaccine Market:

  • Monovalent varicella vaccine occupied two-thirds share of the global varicella live vaccine market in 2018
  • The herpes zoster segment is anticipated to grow with the highest CAGR throughout the forecast period
  • The private segment accounted for two-third share of the market in 2018
  • Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Ram D
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote Varicella Live Vaccine Market by Product (Monovalent Varicella Vaccine and Combination Varicella Vaccine), Application (Chickenpox Immunization, Herpes Zoster Immunization, and MMRV Immunization), and Provider (Public Provider, and Private Provider): Global Opportunity Analysis and Industry Forecast, 2018–2026 quote

View Report
 
 
Avenue Video Loading...

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 3,081 niche industries and company profiles on more than 12,953 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"Global Varicella Live Vaccine Market"
Purchase Enquiry